Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2013 1
2019 2
2020 3
2021 4
2022 2
2023 5
2024 6
2025 4
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Clofarabine monotherapy in aggressive, relapsed and refractory Langerhans cell histiocytosis.
Parekh D, Lin H, Batajoo A, Peckham-Gregory E, Karri V, Stanton W, Scull B, Fleishmann R, El-Mallawany N, Eckstein OS, Prudowsky ZD, Gulati N, Agrusa JE, Ahmed AZ, Chu R, Dietz MS, Goldman SC, Hogarty MD, Imran H, Intzes S, Kim JM, Kopp LM, Levy CF, Neff P, Pillai PM, Sisk BA, Schiff DE, Trobaugh-Lotrario AD, Walkovich K, McClain KL, Allen CE. Parekh D, et al. Among authors: intzes s. Br J Haematol. 2024 May;204(5):1888-1893. doi: 10.1111/bjh.19376. Epub 2024 Mar 19. Br J Haematol. 2024. PMID: 38501389 Free PMC article.
How we approach hemangiomas in infants.
Mayer JLR, Intzes S, Oza VS, Blei F. Mayer JLR, et al. Among authors: intzes s. Pediatr Blood Cancer. 2022 Aug;69 Suppl 3:e29077. doi: 10.1002/pbc.29077. Epub 2021 Jun 20. Pediatr Blood Cancer. 2022. PMID: 34151510
Treatment practices and response in kaposiform hemangioendothelioma: A multicenter cohort study.
Borst AJ, Eng W, Griffin M, Ricci KW, Engel E, Adams DM, Dayneka J, Cohen-Cutler SJ, Andreoli SM, Wu MD, Wheeler AP, Heym KM, Crary SE, Nakano TA, Schulte RR, Setty BA, McLean TW, Pahl KS, Intzes S, Pateva I, Teitelbaum M, Zong Z, Li Y, Jeng MR. Borst AJ, et al. Among authors: intzes s. Pediatr Blood Cancer. 2024 Mar;71(3):e30779. doi: 10.1002/pbc.30779. Epub 2023 Dec 10. Pediatr Blood Cancer. 2024. PMID: 38073018
Emapalumab Treatment in Patients With Rheumatologic Disease-Associated Hemophagocytic Lymphohistiocytosis in the United States: A Retrospective Medical Chart Review Study.
Chandrakasan S, Allen CE, Bhatla D, Carter J, Chien M, Cooper R, Draper L, Eckstein OS, Hanna R, Hays JA, Hermiston ML, Hinson AP, Hobday PM, Isakoff MS, Jordan MB, Leiding JW, Modica R, Nakano TA, Oladapo A, Patel SA, Pednekar P, Riskalla M, Sarangi SN, Satwani P, Tandra A, Walkovich KJ, Yee JD, Zoref-Lorenz A, Behrens EM; REAL‐HLH investigators. Chandrakasan S, et al. Arthritis Rheumatol. 2025 Feb;77(2):226-238. doi: 10.1002/art.42985. Epub 2024 Nov 5. Arthritis Rheumatol. 2025. PMID: 39245963 Free PMC article.
Emapalumab use in malignancy-associated hemophagocytic lymphohistiocytosis in the United States: the REAL-HLH study.
Zoref-Lorenz A, Allen CE, Behrens EM, Chandrakasan S, Chien M, Hermiston ML, Hinson AP, Intzes S, Isakoff MS, Leiding JW, Oladapo A, Panigrahi A, Patel SA, Pednekar P, Ray AK, Rothman JA, Saldaña BD, Walkovich KJ, Weinstein J, Yee JD, Jordan MB, Weinstein J, Hinson AP, Allen CE, Eckstein OS, Gulati N, Chandrakasan S, Haines H, Nakano TA, Patel SA, Behrens EM, Intzes S, Hays A, Saldaña BD, Jordan MB, Zoref-Lorenz A, Hanna R, Isakoff M, Ray AK, Rothman JA, Tandra A, Cooper R, Leiding JW, Chien M, Sarangi S, Gidvani-Diaz VK, Satwani P, Carter J, Henry M, Gloude N, Bhatt S, Bhatla D, Draper L, Panigrahi A, Hermiston ML, Modica R, Riskalla M, Baker A, Ward B. Zoref-Lorenz A, et al. Among authors: intzes s. Blood Adv. 2026 Mar 10;10(5):1564-1575. doi: 10.1182/bloodadvances.2024013690. Blood Adv. 2026. PMID: 41337692 Free PMC article.
Siltuximab monotherapy improves progression free survival compared to rituximab-based therapies in patients with idiopathic multicentric Castleman disease; indirect comparison of studies using single-arm metanalysis method and the generalized linear mixed model.
Karatisidis L, Mprotsis T, Intzes S, Zagoridis K, Vrachiolias G, Karatisidou V, Bezirgianidou Z, Liapis K, Kotsianidis I, Spanoudakis E. Karatisidis L, et al. Among authors: intzes s. Ann Hematol. 2025 Dec;104(12):6229-6235. doi: 10.1007/s00277-025-06560-2. Epub 2025 Dec 5. Ann Hematol. 2025. PMID: 41345785 Free PMC article.
Reproductive Failure and Thrombophilia: Not Enough Evidence for a Tight Bond.
Stamou M, Intzes S, Symeonidou M, Bazntiara I, Bezirgiannidou Z, Pentidou A, Misidou C, Liapis K, Margaritis D, Kotsianidis I, Spanoudakis E. Stamou M, et al. Among authors: intzes s. Acta Haematol. 2022;145(2):170-175. doi: 10.1159/000520439. Epub 2021 Dec 8. Acta Haematol. 2022. PMID: 34879375
P-wave duration and interatrial block as predictors of new-onset atrial fibrillation: A systematic review and meta-analysis.
Zagoridis K, Koutalas E, Intzes S, Symeonidou M, Zagoridou N, Karagogos K, Spanoudakis E, Kanoupakis E, Kochiadakis G, Dinov B, Dagres N, Hindricks G, Bollmann A, Nedios S. Zagoridis K, et al. Among authors: intzes s. Hellenic J Cardiol. 2023 Jul-Aug;72:57-64. doi: 10.1016/j.hjc.2023.03.007. Epub 2023 Apr 5. Hellenic J Cardiol. 2023. PMID: 37028490 Free article.
24 results